303 related articles for article (PubMed ID: 16741553)
1. Therapy insight: Management of hepatorenal syndrome.
Cárdenas A; Ginès P
Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
[TBL] [Abstract][Full Text] [Related]
2. Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
Cárdenas A
Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of hepatorenal syndrome.
Ginès P
Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in hepatorenal syndrome.
Arroyo V; Torre A; Guevara M
Trop Gastroenterol; 2005; 26(1):13-20. PubMed ID: 15974232
[TBL] [Abstract][Full Text] [Related]
5. Hepatorenal syndrome.
Bataller R; Ginès P; Guevara M; Arroyo V
Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
[TBL] [Abstract][Full Text] [Related]
6. Hepatorenal syndrome.
Bataller R; Arroyo V; Ginès P; Sort P
Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
[TBL] [Abstract][Full Text] [Related]
7. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
Arroyo V
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
[TBL] [Abstract][Full Text] [Related]
8. Hepatorenal syndrome.
Ginès P; Guevara M; Arroyo V; Rodés J
Lancet; 2003 Nov; 362(9398):1819-27. PubMed ID: 14654322
[TBL] [Abstract][Full Text] [Related]
9. Review article: pharmacological treatment of hepatorenal syndrome.
Ginès P; Torre A; Terra C; Guevara M
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():57-62; discussion 63-4. PubMed ID: 15335404
[TBL] [Abstract][Full Text] [Related]
10. New challenge of hepatorenal syndrome: prevention and treatment.
Wong F; Blendis L
Hepatology; 2001 Dec; 34(6):1242-51. PubMed ID: 11732014
[TBL] [Abstract][Full Text] [Related]
11. Hepatorenal syndrome.
Guevara M; Rodés J
Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
[TBL] [Abstract][Full Text] [Related]
12. Hepatorenal syndrome.
Biswas KD; Jain AK
Trop Gastroenterol; 2002; 23(3):113-6. PubMed ID: 12693150
[TBL] [Abstract][Full Text] [Related]
13. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology and treatment of hepatorenal syndrome.
Wong F; Blendis L
Gastroenterologist; 1998 Jun; 6(2):122-35. PubMed ID: 9660529
[TBL] [Abstract][Full Text] [Related]
15. Hepatorenal syndrome: new perspectives in pathophysiology and management.
Kes P
Acta Med Croatica; 2000; 54(4-5):165-73. PubMed ID: 11379481
[TBL] [Abstract][Full Text] [Related]
16. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
Gülberg V; Gerbes AL
Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953
[TBL] [Abstract][Full Text] [Related]
17. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
Møller S; Henriksen JH
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
[TBL] [Abstract][Full Text] [Related]
18. Review article: prognosis of hepatorenal syndrome--has it changed with current practice?
Angeli P
Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():44-6; discussion 47-8. PubMed ID: 15335400
[TBL] [Abstract][Full Text] [Related]
19. Hepatorenal syndrome.
Cárdenas A; Arroyo V
Ann Hepatol; 2003; 2(1):23-9. PubMed ID: 15094702
[TBL] [Abstract][Full Text] [Related]
20. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.
Moreau R; Lebrec D
Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
